COVID-19 AND NEUROMUSCULAR DISEASES EP.24 COVID-19 mitigation strategies for outcome measure assessments, training, and endpoint collection in clinic, clinical trials and natural history studies

Field	Value	Language
dc.contributor.author	James, M.	en
dc.contributor.author	Alfano, L.	en
dc.contributor.author	Rose, K.	en
dc.contributor.author	Lowes, L.	en
dc.contributor.author	Eagle, M.	en
dc.date.accessioned	2021-11-26T05:05:12Z
dc.date.available	2021-11-26T05:05:12Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/2123/27052
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	COVID-19 AND NEUROMUSCULAR DISEASES EP.24 COVID-19 mitigation strategies for outcome measure assessments, training, and endpoint collection in clinic, clinical trials and natural history studies	en
dc.type	Article	en
dc.identifier.doi	10.1016/j.nmd.2021.07.049
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health	en

Associated file/s

There are no files associated with this item.